237 related articles for article (PubMed ID: 34231239)
21. Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD.
Yang X; Sun D; Xiang H; Wang S; Huang Y; Li L; Cheng X; Liu H; Hu F; Cheng Y; Ma T; Hu M; Tian H; Tian S; Zhou Y; Zhang P; Zhang XJ; Ji YX; Hu Y; Li H; She ZG
Hepatology; 2021 Sep; 74(3):1319-1338. PubMed ID: 33894019
[TBL] [Abstract][Full Text] [Related]
22. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.
Liu X; Wang K; Wang L; Kong L; Hou S; Wan Y; Ma C; Chen J; Xing X; Xing C; Jiang Q; Zhao Q; Cui B; Huang Z; Li P
Hepatology; 2023 Aug; 78(2):562-577. PubMed ID: 35931467
[TBL] [Abstract][Full Text] [Related]
24. Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.
Yao X; Dong R; Hu S; Liu Z; Cui J; Hu F; Cheng X; Wang X; Ma T; Tian S; Zhang XJ; Hu Y; Bai L; Li H; Zhang P
J Lipid Res; 2023 Jul; 64(7):100382. PubMed ID: 37116711
[TBL] [Abstract][Full Text] [Related]
25. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53.
Lin W; Zhang X; Zhang C; Li L; Zhang J; Xie P; Zhan Y; An W
Lab Invest; 2022 Oct; 102(10):1075-1087. PubMed ID: 35672379
[TBL] [Abstract][Full Text] [Related]
27. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
28. F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit.
Liu Z; Chen NY; Zhang Z; Zhou S; Hu SY
World J Gastroenterol; 2023 Jul; 29(28):4433-4450. PubMed ID: 37576703
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
30. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
31. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
32. SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR.
Song J; Liu Y; Wan J; Zhao GN; Wang JC; Dai Z; Hu S; Yang L; Liu Z; Fu Y; Dong E; Tang YD
Hepatology; 2021 Dec; 74(6):3091-3109. PubMed ID: 34320238
[TBL] [Abstract][Full Text] [Related]
33. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
[TBL] [Abstract][Full Text] [Related]
34. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner.
Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P
FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540
[TBL] [Abstract][Full Text] [Related]
35. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
36. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
37. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C
Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979
[TBL] [Abstract][Full Text] [Related]
38. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
40. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
